If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.
Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Neoen S.A. | NEOEN | Apr 25, 2025 | 39.00 | 0.00 |
Neolife | ALNLF | Apr 25, 2025 | 0.08 | 0.00 |
Neovacs | ALNEV | Apr 25, 2025 | 0.01 | -23.08 |
Netgem | ALNTG | Apr 25, 2025 | 0.96 | +1.55 |
NetMedia Group | ALNMG | Apr 25, 2025 | 1.35 | +0.73 |
Neurones | NRO | Apr 25, 2025 | 46.70 | +0.11 |
Nexans SA | NEX | Apr 25, 2025 | 90.90 | +1.91 |
Nexity SA | NXI | Apr 25, 2025 | 8.98 | -3.08 |
Next 150 Index | N150 | Apr 25, 2025 | 3 349.93 | +0.72 |
Nextedia | ALNXT | Apr 25, 2025 | 0.51 | -0.79 |
NFL Biosciences S.A. | ALNFL | Apr 25, 2025 | 1.50 | +3.45 |
Nicolas Miguet and Associes S.A | MLNMA | Apr 25, 2025 | 0.15 | -20.21 |
Nicox SA | ALCOX | Apr 25, 2025 | 0.23 | +3.54 |
Nokia | NOKIA | Apr 25, 2025 | 4.38 | +3.08 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NBA | Apr 25, 2025 | 7.60 | -0.65 |
Novacyt | ALNOV | Apr 25, 2025 | 0.47 | -2.11 |
Novatech Industries | MLNOV | Apr 25, 2025 | 10.00 | 0.00 |
NR 21 | NR21 | Apr 25, 2025 | 34.00 | 0.00 |
NRJ Group | NRG | Apr 25, 2025 | 6.54 | -2.10 |
NSC Groupe | ALNSC | Apr 25, 2025 | 63.50 | 0.00 |
NSE SA | ALNSE | Apr 25, 2025 | 43.00 | +0.47 |
Obiz | ALBIZ | Apr 25, 2025 | 4.38 | -0.45 |
Odyssee Technologies S.A. | ALODY | Apr 25, 2025 | 19.00 | +1.17 |
Oeneo | SBT | Apr 25, 2025 | 9.00 | -0.66 |
Omer-Decugis & Cie | ALODC | Apr 25, 2025 | 4.28 | +1.18 |
Oncodesign Precision Medicine S.A | ALOPM | Apr 25, 2025 | 0.38 | +2.43 |
One Experience | ALEXP | Apr 25, 2025 | 0.30 | +2.74 |
Onlineformapro | MLONL | Apr 25, 2025 | 0.90 | 0.00 |
OPmobility | OPM | Apr 25, 2025 | 9.59 | -0.52 |
Orange. | ORA | Apr 25, 2025 | 12.33 | -2.95 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.